Biotechnology market research reports by DelveInsight

• Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2022

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 1,250

  “ Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Angiotensin Converting Enzyme (ACE) Inhibitor development. The report provides detaile ... Read More

• HIV integrase inhibitors - Pipeline Insight, 2022

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 1,500

  “ HIV integrase inhibitors - Pipeline Insight, 2021 ,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in HIV integrase inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeut ... Read More

• Gene therapy in rare diseases - Epidemiology Forecast - 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" Gene therapy in rare diseases - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Gene therapy in rare diseases epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Ki ... Read More

• 22q11.2 Deletion Syndrome - Epidemiology Forecast to 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" 22q11.2 Deletion Syndrome - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted 22q11.2 Deletion Syndrome epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), ... Read More

• Gene and Cell Therapies targeting CNS disorders - Epidemiology Forecast - 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" Gene and Cell Therapies targeting CNS disorders - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Gene and Cell Therapies targeting CNS disorders epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spa ... Read More

• Guillain-Barre Syndrome (GBS) - Epidemiology Forecast to 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" Guillain-Barre Syndrome (GBS) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Guillain-Barre Syndrome (GBS) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Ki ... Read More

• Cytokine Release Syndrome (CRS)-Epidemiology Forecast–2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" Cytokine Release Syndrome (CRS) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Cytokine Release Syndrome (CRS) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the Unite ... Read More

• MOG Antibody Disease - Epidemiology Forecast - 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" MOG Antibody Disease - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted MOG Antibody Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. ... Read More

• Anti-CD40 Antibody - Pipeline Insight, 2022

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 1,250

  “ Anti-CD40 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD40 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More

• Anti-CD152 Antibody - Pipeline Insight, 2022

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 1,250

  “ Anti-CD152 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD152 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechan ... Read More

• Anti-CD37 Antibody - Pipeline Insight, 2022

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 1,250

  “ Anti-CD37 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD37 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More

• Protein tyrosine phosphatase non receptor type 11 antagonists - Pipeline Insight, 2022

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 1,500

  “ Protein tyrosine phosphatase non receptor type 11 antagonists - Pipeline Insight, 2022 ” report provides comprehensive insights about 7+ companies and 8+ pipeline drugs in Protein tyrosine phosphatase non receptor type 11 antagonists pipeline landscape. It covers the pipeline drug profiles, includ ... Read More

• Dense Deposit Disease - Epidemiology Forecast - 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" Dense Deposit Disease - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Dense Deposit Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japa ... Read More

< prev 4 5 6 7 8 9 next >